Hyfusin Group Holdings Limited Overview
Hyfusin is a Hong Kong-headquartered, Vietnam-based contract manufacturer of candles and home-fragrance products, selling almost exclusively to department-store operators and buying agents headquartered in the United States and United Kingdom. It manufactures largely to customer specification — essentially private-label/OEM supply with design-support, sampling, laboratory testing and material-procurement services layered on top. Scented candles account for roughly 71–74% of revenue, and the US for 87–93%. The business is small (FY2025 revenue HK$898.1M, ≈US$115M) and highly concentrated: one customer contributed 45% of FY2025 sales and as much as 63% in FY2023. Its competitive position rests on a low-cost, increasingly automated Vietnamese production base (three factories, two built since 2021), long customer relationships and a very conservative balance sheet (net cash ≈HK$393M at FY2025 versus a market capitalisation of ≈HK$344M). Its key vulnerabilities are customer concentration, US tariff exposure, price pressure and, since 2025, deteriorating margins and receivable quality.
Company's own description (paraphrased from FY2025 and FY2024 results announcements)
The FY2025 results announcement describes the group as a leading manufacturer and distributor of high-quality candles — scented, decorative and daily-use — together with home-fragrance items such as diffusers, headquartered in Hong Kong with core manufacturing primarily in Vietnam [S1]. It states that its primary focus is the mid-to-high-end segment in the US and UK, serving major department-store operators and professional buying agents, and that it mainly manufactures to customers' requirements and specifications [S1]. Value-added services listed include product design, material procurement, pre-production sampling, laboratory testing and quality-improvement recommendations [S1][S2]. Revenue disaggregation notes confirm that the group's market comprises department stores and buying agents headquartered in the US and UK, that contracts are short-term with fixed prices, and that all revenue is recognised at a point in time when goods ship to the customer-specified location [S1].
Business model and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Revenue type | 100% product sales; no service, subscription or licensing revenue reported | All revenue "sale of candle products", recognised at a point in time [S1] |
| Contract structure | Short-term purchase orders, fixed prices agreed per order; performance obligations ≤1 year | [S1] |
| Customer types | US/UK department-store operators and buying agents (i.e., retailers' sourcing arms) | [S1][S2] |
| Manufacturing model | Build-to-specification (OEM/private label) with ODM-like design input | [S2][S3] |
| Sales channel | Direct B2B sales plus incentive-based third-party sales representatives in the US (since 2018) | [S1][S4] |
| Production footprint | Vietnam (Dong Nai Province) factories; Hong Kong HQ; Singapore subsidiary; small US non-current asset base from FY2025 | [S1] |
| Functional currency / pricing | USD functional currency; sales effectively USD-priced; costs partly in VND and HKD | [S1] |
| Credit terms | 30–180 days to trade customers (FY2025); 30–120 days in FY2021 | [S1][S4] |
Value-chain position
Hyfusin sits in the middle of the home-fragrance value chain: it buys wax, fragrance oils, wicks, glass vessels and packaging; formulates, pours and finishes candles in Vietnam; and ships to retailers who own the consumer brand, merchandising and pricing. It does not appear to own consumer brands or operate retail channels (no brand revenue is disclosed in filings reviewed). Its economic leverage therefore derives from manufacturing cost, quality, speed of sampling/design iteration and compliance capability (e.g., laboratory testing), not from brand equity.
End-markets
| End-market | Exposure | Evidence |
|---|---|---|
| US home décor / home fragrance retail (department stores, mass/discount retailers via buying agents) | 86.6% of FY2025 revenue; 93.1% of 1H2026 revenue | [S1][S5] |
| UK home décor / home fragrance retail | 12.2% of FY2025 revenue; 6.8% of 1H2026 | [S1][S5] |
| Other markets | 1.2% of FY2025 revenue | [S1] |
Independent characterisation
Hyfusin is best understood as a single-segment, export-oriented private-label candle factory whose fortunes are tied to the purchasing cycles of a handful of large US retailers. The business enjoyed an exceptional 2020–2024 period (revenue +64% from FY2020 to FY2024; gross margin peaking at 38.7% in FY2023–24) as US home-fragrance demand rose during and after the pandemic and wax costs normalised. From FY2025 the cycle has turned: average selling prices fell, production costs rose, the largest customer's purchases dropped 19%, receivable impairments climbed sharply, and 1H2026 net profit fell 56.6% year on year [S1][S5]. Against that, the group's balance sheet is unusually strong for its size: at 31 Dec 2025 cash of HK$405.6M exceeded total liabilities (HK$112.7M) by more than three times [S1]. The equity story is therefore one of a cash-rich, tightly controlled family company trading at a discount to its net cash, with operating momentum currently negative.
Strategy
Stated strategy (themes from the latest annual results)
The FY2025 announcement's outlook frames the environment as challenging and commits to three levers: proactive marketing, more resources for product development, and reinforced cost control [S1]. Management also describes the aim of being "the competitive manufacturer among the industry" [S1]. Operational themes repeated across FY2023–FY2025 are: (i) capacity and automation in Vietnam (two highly automated factories from 2022 and 2024 plus renovation of the original facility); (ii) incentive-based US sales representatives to win new business; (iii) liquidity improvement by reducing external borrowings during the high-rate period; and (iv) leveraging long-standing customer relationships and a "diversified production strategy" to navigate external uncertainty, especially US tariff policy [S1][S2][S3]. No investor day has been held or transcript published.
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Detail | Targets / spend | Source |
|---|---|---|---|---|
| Renovation of original production facility | Oct 2024 – Dec 2025 | Contract VND32.68bn (≈HK$10.1M); ≈VND31.4bn (≈HK$9.8M) paid; completed by 31 Dec 2025 | Efficiency improvement; no quantified target | [S1] |
| Third factory commissioning | 2,024 | Plot 56 factory and warehouse | Capacity expansion; no capacity figures disclosed | [S2] |
| Automation capex | 1H2026 | HK$23.07M PPE investment, mainly automation in Vietnam | Not quantified | [S5] |
| US sales representatives | Ongoing; reiterated FY2025 | Incentive-based contracts to capture new US business | Not quantified | [S1] |
| Debt reduction | FY2024–FY2025 | Bank borrowings cut from HK$15.0M to HK$8.3M | Gearing 1.6% at FY2025 | [S1] |
| Share option scheme | Adopted 7 Jun 2024 | Employee incentive tool; unused to 30 Jun 2026 | — | [S2][S5] |
| Tariff monitoring/mitigation | FY2025 | Management states it has implemented strategic initiatives to protect US competitiveness (not specified) | Not specified | [S1] |
Sustainability/ESG commitments: not identified in sources reviewed. Cost programmes with targets: none quantified. Medium-term financial targets / guidance: none provided; the company issues profit alerts/warnings under GEM Rule 17.10 rather than formal guidance [S6][S19].
Analyst view of strategy
The strategy is operational rather than transformational: more automated capacity in Vietnam, cost control and sales-rep-led customer acquisition. There is no disclosed plan for own-brand development, e-commerce, geographic diversification beyond the US/UK, or capital return — despite the balance sheet strongly supporting the latter. With capacity now expanded and demand softening, utilisation (undisclosed) is the key unknown for margins.
Products & Services
The group does not publish a product catalogue, SKU count, brand list or pricing in its statutory filings; the products are largely made to customer specification and sold under retailers' own brands. The catalogue below is therefore assembled from category disclosures, the recall announcement and third-party profiles; anything beyond these is marked not publicly disclosed.
Sources: [S1][S5][S9][S12].
Value-added services (bundled, not separately priced): product design and design suggestions on customer specifications; raw-material selection and procurement; provision of sample candles before mass production; laboratory testing; and recommendations for quality improvement [S1][S2]. These are not separately invoiced — no service revenue is reported — but they underpin customer stickiness. The group's major customer recognised it with a "Business Partner Award Winner for Differentiate Owned Brands" in 2020 and 2021 for helping develop that customer's candle category [S4].
Launch/version years: not publicly disclosed for any product.
Product Portfolio
| Product line | Description (from filings) | Key specs / capabilities | Target customer | Latest disclosed revenue | Pricing model | Named flagship offerings |
|---|---|---|---|---|---|---|
Scented candles | Candles with fragrance and colour additives; group's best-selling category every year FY2020–FY2025 | Formats include glass-jar candles (confirmed by the Dec 2023 recall of ≈7.1M glass-jar units); other vessel types not disclosed | US/UK department stores and buying agents, mid-to-high-end segment | HK$639.2M (FY2025, 71.2%); HK$252.2M (1H2026, 73.8%) | Fixed per-order prices; short-term contracts | Not publicly disclosed (private label) |
Daily-use candles | Functional/unscented-type everyday candles (precise formats not specified) | — | Same | HK$112.3M (FY2025, 12.5%) | Same | — |
Decorative candles | Candles sold primarily for decorative/seasonal display | — | Same | HK$50.2M (FY2025, 5.6%) | Same | — |
Others, incl. diffusers | Home-fragrance products, principally reed/fragrance diffusers | Not publicly disclosed; third-party profile of Fleming International (HK) also lists poly-resin photo frames, bath products and candle holders as historical lines (not confirmed in current filings) | Same | HK$96.4M (FY2025, 10.7%) | Same | — |
“—” = not publicly disclosed.
Financial Narrative
All figures HKD M, fiscal years ended 31 December, audited, per results announcements [S1][S2][S3][S4] unless labelled. FY2020 included for context where useful.
Income statement
Non-recurring items: FY2023 includes a HK$53.0M recall provision in selling expenses; FY2024 includes a HK$29.7M reversal of that provision in other gains; FY2025 includes a HK$15.3M trade-receivable impairment [S1][S2][S3]. Management's adjusted net profit: FY2023 HK$155.3M ex-provision; FY2024 HK$141.7M ex-reversal [S3][S2].
Computed from filed figures. Revenue CAGR FY2021–FY2025 (4 years): 2.5%; FY2020–FY2025 (5 years): 10.1% (computed).
Commentary — income statement. Three distinct phases are visible. (1) Pandemic boom, FY2020–21: revenue jumped 46.6% in FY2021 on scented (+HK$230.2M) and daily-use (+HK$48.3M) demand, but gross margin fell from 37.2% to 33.1% because average wax cost rose ≈37% [S4]. (2) Destocking and recovery, FY2022–24: FY2022 revenue fell 16% amid US retailer destocking and gross margin bottomed at 30.3%; FY2023 delivered record revenue and a 38.7% gross margin on lower raw-material prices and overhead absorption from the automated second factory [S3]. FY2024 added another 5% of revenue at a constant 38.7% margin [S2]. (3) Margin compression, FY2025–1H2026: gross margin collapsed to 31.6% in FY2025 on lower selling prices and higher production costs [S1], and to 28.6% in 1H2026 [S5]. The FY2025 decline in administrative expenses (−22%, mostly HK$31.5M lower salaries/bonuses) cushioned operating profit [S1], but this is a cyclical bonus effect rather than structural efficiency. Finance costs remain high relative to tiny gross debt because the group carries VND loans at 5.7–8.0% and historically used supplier-finance facilities [S1].
Half-year trend
1H2026 per [S5]; 1H2025 values per [S5] where stated, otherwise derived from stated percentage changes (1H2025 gross profit derived from −14.16%; admin from −12.82%; S&D from −1.4%; other income from −46.5%; finance costs from −25.08%) — derived items are approximations. 1H2026 included a HK$13.43M trade-receivable impairment [S5].
Balance sheet
Sources: [S4] FY2021; [S3] FY2022–23; [S2] FY2024; [S1] FY2025. Goodwill/intangibles: none reported on the face of the balance sheet. The FY2022 land-use right acquisition (≈HK$31.9M) is classified within right-of-use assets.
At 30 Jun 2026 [S5]: net assets HK$768.04M; total liabilities HK$195.02M (so total assets ≈HK$963.1M, computed); bank borrowings HK$30.85M; gearing 4.7%. Cash balance at 30 Jun 2026 not available in the summaries reviewed.
Commentary — balance sheet. Equity has more than doubled since FY2021 (HK$330M → HK$748M) through retained earnings, with no dividends paid. Gross bank debt fell from HK$62.6M to HK$8.3M, and the company-defined gearing ratio (total debt incl. leases ÷ equity) dropped from 20.0% to 1.6% [S1][S4]. The asset base has shifted toward fixed assets (PPE up from HK$60.7M to HK$172.4M) as the group built two factories and renovated a third. The principal balance-sheet warning sign is receivable quality: gross trade receivables doubled in FY2024 (HK$65.7M → HK$133.4M) and the credit-loss allowance jumped from HK$2.4M to HK$17.7M in FY2025; receivables more than 180 days old by invoice date rose from HK$1.0M to HK$13.0M [S1][S2]. Another HK$13.4M impairment was booked in 1H2026 [S5]. Credit terms have also lengthened from 30–120 days (FY2021) to 30–180 days [S4][S1].
Cash flow
Source: [S10] (S&P Global Market Intelligence data). The preliminary results announcements reviewed do not reproduce the cash flow statement; cross-check: PPE additions per filings were HK$67.2M (FY2024) and HK$53.9M (FY2025) [S1], consistent in magnitude with aggregator capex once deposits paid are considered. Buyback amount (HK$30.0M) agrees with [S7].
Commentary — cash flow. FY2023 operating cash flow (HK$307M) was flattered by HK$154M of working-capital release, including a large rise in payables/accruals and the non-cash HK$53M recall provision. FY2024 reversed part of this (receivables +HK$70.9M). FY2025 operating cash flow of HK$202M benefited from inventory reduction (−HK$25.4M) and receivable collection. Cumulative FY2021–FY2025 free cash flow was ≈HK$558M (computed), of which only HK$30M was returned to shareholders (the 2024 buyback); the remainder accumulated as cash or repaid debt.
Ratios
All computed from filed figures (year-end balances for DIO/DSO/DPO; average balances for ROE/ROA; ROIC uses core operating profit × (1 − effective tax rate) over year-end equity + total debt − cash). Debt-to-equity matches the company's reported gearing ratio in every year [S1][S2][S3][S4]. Aggregator ROE for FY2025 TTM is cited as 18.23% by Wisesheets, which uses a different denominator — discrepancy noted.
Commentary — ratios. Returns are high for a manufacturer because the capital base excluding cash is small; ROIC remained near 30% even in the weaker FY2025. However, ROE is being diluted by the growing cash pile (cash ≈54% of equity at FY2025), and asset turnover has fallen every year since FY2021 as capacity was added ahead of demand. Inventory discipline improved markedly in FY2025 (DIO 47 days, from 93 in FY2021), offset by slower collections.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Role |
|---|---|---|
Hyfusin Group Holdings Limited | Cayman Islands | Listed holding company |
AVW International Limited | BVI | Parent and ultimate holding company (70.06%) |
Fleming Group International Limited | Not stated in filings reviewed | Intermediate holding company; co-guarantor of bank facilities |
Fleming International Limited ("Fleming Hong Kong") | Hong Kong | Trading/operating company; HK profits tax payer |
Fleming International Vietnam Limited ("Fleming Vietnam") | Vietnam | Manufacturing subsidiary (20% CIT) |
Fleming International (Singapore) Pte. Limited | Singapore | Subsidiary (17% CIT); function not described in filings reviewed |
Success Glory Worldwide Ltd | Not stated | — |
Product category revenue (HKD Mn)
| Product category revenue (HKD Mn) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Daily-use candles | 98.08 | 146.38 | 110.68 | 111.59 | 123.89 | 112.25 |
Scented candles | 339.72 | 569.97 | 477.28 | 612.18 | 603.58 | 639.25 |
Decorative candles | 17.43 | 18.69 | 10.15 | 27.31 | 33.75 | 50.22 |
Others incl. diffusers | 100.68 | 80.12 | 86.83 | 115.17 | 148.23 | 96.39 |
Total revenue | 555.91 | 815.14 | 684.95 | 866.25 | 909.45 | 898.11 |
Product category share of revenue (%)
| Product category share of revenue (%) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Daily-use candles share (%) | 17.6 | 18.0 | 16.2 | 12.9 | 13.6 | 12.5 |
Scented candles share (%) | 61.1 | 69.9 | 69.7 | 70.7 | 66.4 | 71.2 |
Decorative candles share (%) | 3.1 | 2.3 | 1.5 | 3.2 | 3.7 | 5.6 |
Others incl. diffusers share (%) | 18.1 | 9.8 | 12.7 | 13.3 | 16.3 | 10.7 |
Product category YoY growth (%)
| Product category YoY growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Daily-use candles YoY (%) | 49.2 | -24.4 | 0.8 | 11.0 | -9.4 |
Scented candles YoY (%) | 67.8 | -16.3 | 28.3 | -1.4 | 5.9 |
Decorative candles YoY (%) | 7.2 | -45.7 | 168.9 | 23.6 | 48.8 |
Others incl. diffusers YoY (%) | -20.4 | 8.4 | 32.6 | 28.7 | -35.0 |
Total revenue YoY (%) | 46.6 | -16.0 | 26.5 | 5.0 | -1.2 |
Product category revenue, half-year (HKD Mn)
| Product category revenue, half-year (HKD Mn) | 1H2025 | 1H2026 |
|---|---|---|
Scented candles | 268.85 | 252.17 |
Total revenue | 369.84 | 341.87 |
Income statement (HKD Mn)
| Income statement (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 815.14 | 684.95 | 866.25 | 909.45 | 898.11 |
Cost of sales | 545.22 | 477.26 | 530.71 | 557.55 | 614.17 |
Gross profit | 269.92 | 207.69 | 335.54 | 351.90 | 283.94 |
Other income | 1.81 | 3.53 | 9.11 | 17.70 | 19.17 |
Other gains and losses net | -3.30 | 1.03 | 1.76 | 32.33 | -12.76 |
Selling and distribution expenses | 37.14 | 26.98 | 86.17 | 42.35 | 41.94 |
Administrative expenses | 96.59 | 86.95 | 110.71 | 144.99 | 112.90 |
Core operating profit (GP less S&D less admin, computed) | 136.19 | 93.76 | 138.66 | 164.55 | 129.09 |
EBIT (PBT plus finance costs, computed) | 134.70 | 98.31 | 149.53 | 214.59 | 135.50 |
Depreciation and amortisation (S&P aggregator) | 4.49 | 5.23 | 5.40 | 6.65 | 7.93 |
EBITDA (core op. profit plus aggregator D&A, computed) | 140.68 | 98.99 | 144.06 | 171.20 | 137.02 |
Finance costs | 4.91 | 8.81 | 14.57 | 11.77 | 10.99 |
Profit before tax | 129.79 | 89.50 | 134.96 | 202.82 | 124.51 |
Income tax | 23.58 | 16.44 | 32.67 | 31.39 | 23.05 |
Net profit attributable to owners | 106.21 | 73.06 | 102.29 | 171.43 | 101.47 |
Basic EPS (HK cents) | 9.66 | 6.64 | 9.30 | 17.58 | 11.05 |
Diluted EPS (HK cents) | 9.66 | 6.64 | 9.30 | 17.58 | 11.05 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margins and growth (%)
| Margins and growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 33.1 | 30.3 | 38.7 | 38.7 | 31.6 |
Core operating margin (%) | 16.7 | 13.7 | 16.0 | 18.1 | 14.4 |
EBITDA margin, aggregator basis (%) | 17.3 | 14.5 | 16.6 | 18.8 | 15.3 |
Pre-tax margin (%) | 15.9 | 13.1 | 15.6 | 22.3 | 13.9 |
Net margin (%) | 13.0 | 10.7 | 11.8 | 18.9 | 11.3 |
Effective tax rate (%) | 18.2 | 18.4 | 24.2 | 15.5 | 18.5 |
Revenue growth YoY (%) | 46.6 | -16.0 | 26.5 | 5.0 | -1.2 |
Net profit growth YoY (%) | 17.4 | -31.2 | 40.0 | 67.6 | -40.8 |
Income Statement and Margin Analysis (%)
| Half-year metric (HKD Mn unless stated) | 1H2025 | 1H2026 |
|---|---|---|
Revenue | 369.84 | 341.87 |
Gross profit | 113.73 | 97.63 |
Gross margin (%) | 30.7 | 28.6 |
Administrative expenses | 48.56 | 42.34 |
Selling and distribution expenses | 16.68 | 16.45 |
Other gains and losses net | 3.99 | -12.64 |
Other income | 7.18 | 3.84 |
Finance costs | 4.40 | 3.30 |
Net profit attributable | 45.15 | 19.59 |
Basic EPS (HK cents) | 4.91 | 2.13 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Balance sheet at 31 Dec (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 482.98 | 501.32 | 686.92 | 796.79 | 861.15 |
Property plant and equipment | 60.72 | 68.91 | 90.94 | 142.09 | 172.38 |
Right-of-use assets | 21.53 | 52.17 | 50.42 | 49.46 | 48.03 |
Inventories | 138.98 | 101.36 | 102.50 | 105.48 | 79.69 |
Trade receivables net | 86.40 | 69.08 | 63.12 | 130.97 | 112.25 |
Bank balances and cash | 138.35 | 171.35 | 336.77 | 324.51 | 405.65 |
Pledged bank deposits (non-current) | 19.90 | 22.14 | 19.35 | 18.30 | 18.36 |
Bank borrowings short-term | 46.91 | 23.25 | 6.34 | 5.07 | 5.08 |
Bank borrowings long-term | 15.67 | 26.46 | 8.67 | 7.66 | 3.27 |
Lease liabilities total | 3.36 | 4.25 | 3.36 | 3.70 | 3.89 |
Total debt incl. leases | 65.94 | 53.96 | 18.37 | 16.43 | 12.24 |
Net debt (negative = net cash, excl. pledged deposits) | -72.41 | -117.39 | -318.40 | -308.08 | -393.41 |
Total liabilities | 152.53 | 98.06 | 181.35 | 149.82 | 112.69 |
Total equity | 330.46 | 403.26 | 505.57 | 646.97 | 748.46 |
Goodwill and intangibles | 0 | 0 | 0 | 0 | 0 |
Net current assets (working capital) | 230.61 | 283.99 | 341.41 | 436.86 | 496.53 |
Trade payables | 45.71 | 18.88 | 39.26 | 45.30 | 46.26 |
Cash flow (HKD Mn, S&P aggregator)
| Cash flow (HKD Mn, S&P aggregator) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | 73.30 | 96.61 | 306.98 | 101.12 | 202.08 |
Capital expenditure | 54.09 | 6.84 | 34.92 | 64.98 | 61.27 |
Land-use right purchase | 0 | 30.48 | 0 | 0 | 0 |
Free cash flow (OCF less capex) | 19.21 | 89.76 | 272.06 | 36.15 | 140.82 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 30.00 | 0 |
Net debt repaid (negative = net issuance) | -21.72 | 15.76 | 95.84 | 20.27 | 63.42 |
Change in working capital | -38.15 | 12.50 | 154.39 | -45.71 | 59.79 |
Cash taxes paid | 33.55 | 26.10 | 10.19 | 41.44 | 24.21 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average equity (%) | 38.3 | 19.9 | 22.5 | 29.7 | 14.5 |
ROA on average assets (%) | 25.4 | 14.8 | 17.2 | 23.1 | 12.2 |
ROIC, NOPAT over year-end invested capital net of cash (%) | 43.2 | 26.8 | 56.2 | 41.0 | 29.6 |
Current ratio (x) | 2.69 | 5.10 | 2.98 | 4.12 | 5.58 |
Total debt to equity (%) | 20.0 | 13.4 | 3.6 | 2.5 | 1.6 |
Net debt to EBITDA (x, negative = net cash) | -0.51 | -1.19 | -2.21 | -1.80 | -2.87 |
Interest coverage, core op. profit over finance costs (x) | 27.7 | 10.6 | 9.5 | 14.0 | 11.7 |
Asset turnover, revenue over average assets (x) | 1.95 | 1.39 | 1.46 | 1.23 | 1.08 |
Days inventory outstanding (days) | 93.0 | 77.5 | 70.5 | 69.1 | 47.4 |
Days sales outstanding (days) | 38.7 | 36.8 | 26.6 | 52.6 | 45.6 |
Days payables outstanding (days) | 30.6 | 14.4 | 27.0 | 29.7 | 27.5 |
Cash conversion cycle (days) | 101.1 | 99.9 | 70.1 | 92.0 | 65.5 |
Revenue by geography (HKD Mn)
| Revenue by geography (HKD Mn) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
United States | 504.20 | 736.27 | 604.97 | 801.38 | 845.57 | 777.79 |
United Kingdom | 44.92 | 68.17 | 72.69 | 60.84 | 59.59 | 109.16 |
Others | 6.79 | 10.70 | 7.29 | 4.03 | 4.30 | 11.16 |
Total | 555.91 | 815.14 | 684.95 | 866.25 | 909.45 | 898.11 |
Geographic share and growth (%)
| Geographic share and growth (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
US share (%) | 90.3 | 88.3 | 92.5 | 93.0 | 86.6 |
UK share (%) | 8.4 | 10.6 | 7.0 | 6.6 | 12.2 |
Others share (%) | 1.3 | 1.1 | 0.5 | 0.5 | 1.2 |
US growth YoY (%) | 46.0 | -17.8 | 32.5 | 5.5 | -8.0 |
UK growth YoY (%) | 51.8 | 6.6 | -16.3 | -2.1 | 83.2 |
Others growth YoY (%) | 57.6 | -31.9 | -44.7 | 6.6 | 159.5 |
Half-year Geography Details
| Half-year geography (HKD Mn) | 1H2026 |
|---|---|
United States | 318.25 |
United Kingdom | 23.12 |
Non-current assets by location (HKD Mn)
| Non-current assets by location (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Hong Kong | 4.09 | 5.04 | 3.94 | 4.38 | 4.57 |
Vietnam | 90.01 | 118.90 | 144.11 | 191.67 | 220.25 |
United States | 0 | 0 | 0 | 0 | 7.44 |
Major customer revenue (HKD Mn)
| Major customer revenue (HKD Mn) | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Customer A | 335.76 | 478.26 | 383.85 | 544.70 | 503.88 | 408.04 |
Customer A share of revenue (%) | 60.4 | 58.7 | 56.0 | 62.9 | 55.4 | 45.4 |
Share Price History
| Date | Price (HKD) | Context |
|---|---|---|
19 Jul 2018 | 0.295 | IPO offer price |
Feb 2024 (last close before buyback announcement) | 0.219 | Pre-announcement close |
20 Feb 2024 | 0.165 | Off-market buyback price |
~Sep 2025 (trailing 12M range) | 0.23 – 0.38 | TipRanks 52-week range at time of capture |
31 Jul 2026 | 0.375 | StockAnalysis quote |
9 Oct 2026 | 0.375 | Latest close available |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation (HKD Mn) | 344.4 | 918.5M shares |
P/E FY2025 (x) | 3.4 | FY2025 net profit HK$101.5M |
P/E TTM Jun-2026 (x) | 4.5 | TTM net profit HK$75.9M (S&P) [S10] |
P/B (x) | 0.45 | Net assets HK$768.0M at 30 Jun 2026 [S5] |
Enterprise value (HKD Mn) | -49.0 | Market cap less FY2025 net cash HK$393.4M (cash at Jun 2026 not available) |
EV/EBITDA FY2025 (x) | negative | Negative EV |
EV/Sales FY2025 (x) | negative | Negative EV |
Dividend yield (%) | 0 | No dividends |
Capital Markets
| Item | Detail | Source |
|---|---|---|
Dividend history | No dividend declared or paid for FY2020–FY2025, nor for 1H2026 | [S1][S2][S3][S4][S5] |
Buybacks | One off-market buyback: 181.5M shares for HK$30.0M (Apr 2024); general repurchase mandates typically sought at AGMs; no on-market repurchases in FY2025 | [S8][S1][S22] |
Credit ratings (Moody's/S&P/Fitch) | None — unrated | — |
Unutilised banking facilities | HK$112.4M (FY2025) | [S1] |
Debt maturity profile at 31 Dec 2025 (HKD Mn) | Within 1 year | 1–2 years |
Bank borrowings by scheduled repayment | 5.08 | 2.22 |
Share Count (M) and Per-Share Data
| Multi-year capital markets data | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Shares in issue at year-end (M) | 1,100.0 | 1,100.0 | 1,100.0 | 918.5 | 918.5 |
Net assets per share (HKD) | 0.300 | 0.367 | 0.460 | 0.704 | 0.815 |
Cash per share (HKD) | 0.126 | 0.156 | 0.306 | 0.353 | 0.442 |
Dividends per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management guidance
No numerical guidance. Management expects the operating environment to remain challenging and plans proactive marketing, more product-development resources and cost control [S1]. The August 2026 profit warning attributes the 1H2026 decline to fewer new customer orders, lower selling prices and higher production costs [S6]. Consensus growth expectations: none available (no analyst coverage).
Bull case
-
Valuation below net cash: at HK$0.375 the market capitalisation (≈HK$344M) is below FY2025 net cash (≈HK$393M), implying a negative enterprise value for a business that generated HK$141M of free cash flow in FY2025 [S10][S1].
-
Trade-diversion optionality: EU anti-dumping duties on Chinese candles (from Aug 2025) [S13] and the US policy tilt against China-made goods could redirect retailer programmes toward Vietnam-based suppliers with existing automated capacity.
-
Operating leverage on new capacity: two automated factories and a renovated original plant are now complete; any order recovery would fall on a largely fixed-cost base, as demonstrated in FY2023 when gross margin rose 8.4 points [S3].
Bear case
-
Earnings in sharp decline with no visible floor: net profit fell 40.8% in FY2025 and 56.6% in 1H2026; gross margin is on a three-period downtrend (38.7% → 31.6% → 28.6%) [S1][S5].
-
Credit and concentration risk compounding: receivable impairments of HK$15.3M (FY2025) and HK$13.4M (1H2026) [S1][S5] coincide with the largest customer cutting purchases by 19% — the downside of 45–63% dependence on one buyer.
-
Value trap governance: a 70%-controlled company that has paid no dividends since at least FY2020 while accumulating cash may never close the discount to net cash; the only capital return (2024) benefited a single exiting shareholder at a discount [S7][S8].
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Expected timing |
|---|---|---|
| FY2026 annual results | Confirms whether 2H2026 stabilises; gross margin trajectory | ~Mar 2027 |
| Profit alert/warning for FY2026 | Early read on 2H trends | ~Feb–Mar 2027 |
| Dividend or buyback decision | Key to closing net-cash discount | With FY2026 results / AGM ~Jun 2027 |
| Customer A revenue and receivable ageing | Concentration and credit risk | FY2026 annual report |
| US tariff decisions affecting Vietnamese imports | Primary demand/margin risk per management | Ongoing |
| Bank borrowings and cash at Dec 2026 | Borrowings rose to HK$30.9M in 1H2026 | FY2026 results |
| Nature of new US assets | Possible strategic shift (US presence) | FY2026 annual report |
| Share option grants | Incentive alignment | Any time |
Analyst verdict
Hyfusin is a classic small-cap Hong Kong "net-net": an efficient, cash-generative Vietnamese contract manufacturer whose equity is valued below the cash on its balance sheet. The FY2020–FY2024 record was genuinely strong — revenue up 64%, gross margin expanded to 38.7%, debt nearly eliminated, two automated factories built and equity more than doubled without external capital. Returns on operating capital remain high even now, and the balance sheet (cash HK$405.6M versus total liabilities HK$112.7M at FY2025) leaves no solvency question.
However, the investment case has shifted from growth to defence. The FY2025 results and the August 2026 profit warning show a business losing pricing power: lower selling prices and higher production costs have stripped ten points from gross margin in eighteen months, and rising receivable impairments suggest stress among customers or tolerance of slower-paying accounts. With 86–93% of sales going to the US and nearly half to one customer, the group is acutely exposed to US tariff policy and to a single buyer's sourcing decisions — neither of which management can control.
The decisive variable for shareholders is capital allocation. A controlling family holding 70% has chosen to retain all earnings since listing, with the sole buyback structured to remove one holder's block. Unless the board begins returning a meaningful portion of the ≈HK$0.44/share cash (FY2025) through dividends or tender offers, the discount to net cash may persist regardless of operating performance.
Verdict: Fundamentally cheap but operationally deteriorating. Near-term earnings momentum is negative; the re-rating trigger would be either a clear margin stabilisation in FY2026 results or a shift in payout policy. Absent either, the stock is more likely to remain a value trap than to close its discount.
SOURCES REGISTER
-
[S1] FY2025 Annual Results Announcement (25 Mar 2026): https://www1.hkexnews.hk/listedco/listconews/gem/2026/0325/2026032501321.pdf
-
[S2] FY2024 Annual Results Announcement (21 Mar 2025): https://www1.hkexnews.hk/listedco/listconews/gem/2025/0321/2025032101599.pdf
-
[S3] FY2023 Annual Results Announcement (26 Mar 2024): https://www1.hkexnews.hk/listedco/listconews/gem/2024/0326/2024032601910.pdf
-
[S4] FY2021 Annual Results Announcement (18 Mar 2022): https://www1.hkexnews.hk/listedco/listconews/gem/2022/0318/2022031801961.pdf
-
[S5] 1H2026 results coverage (Bulletin Express via Tiger Brokers): https://www.itiger.com/news/1177068207 and https://www.itiger.com/news/1117826854
-
[S6] Profit Warning (7 Aug 2026): https://www1.hkexnews.hk/listedco/listconews/gem/2026/0807/2026080700846.pdf
-
[S7] Proposed Off-market Share Buy-back (20 Feb 2024): https://www.hkexnews.hk/listedco/listconews/gem/2024/0220/2024022000682.pdf
-
[S8] Completion of Off-market Share Buy-back (24 Apr 2024): https://www1.hkexnews.hk/listedco/listconews/gem/2024/0424/2024042402112.pdf
-
[S9] Recall of Candle Products (18 Dec 2023): https://www1.hkexnews.hk/listedco/listconews/gem/2023/1218/2023121800336.pdf
-
[S10] StockAnalysis.com cash flow and quote (S&P Global MI data): https://stockanalysis.com/quote/hkg/8512/financials/cash-flow-statement/ and https://stockanalysis.com/quote/hkg/8512/financials/income-statement/
-
[S11] Simply Wall St profile: https://simplywall.st/stock/sehk/8512
-
[S12] MarketScreener insider profiles: https://uk.marketscreener.com/insider/WAI-CHIT-WONG-A2AHU6/ and https://in.marketscreener.com/insider/MAN-CHIT-WONG-A2AHUT/
-
[S13] Kwung's Aroma Holdings results: https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0331/2026033103405.pdf ; https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0331/2025033102601.pdf ; https://stoxray.com/stocks/xhkg/1925
-
[S14] TipRanks: https://www.tipranks.com/stocks/hk:8512 and https://www.tipranks.com/stocks/hk:8512/financials/income-statement
-
[S15] Board meeting notices: https://www1.hkexnews.hk/listedco/listconews/gem/2024/0314/2024031400418.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2025/0729/2025072900327.pdf
-
[S16] Scented candle market summaries (GII): https://cn.gii.tw/report/go1595017-scented-candles.html ; https://www.gii.co.jp/report/dmin1446827-global-scented-candles-market.html
-
[S17] Simply Wall St 1H2025 note (via Webull): https://www.webull.hk/en/news/13427896568603648
-
[S18] Moomoo news feed: https://www.moomoo.com/stock/08512-HK/news/all
-
[S19] Profit alerts: https://www1.hkexnews.hk/listedco/listconews/gem/2021/0728/2021072800473.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2022/0311/2022031100437.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2022/0729/2022072901097.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2023/0315/2023031500347.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2024/0320/2024032000323.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2024/0809/2024080900923.pdf ; https://www1.hkexnews.hk/listedco/listconews/gem/2025/0314/2025031401363.pdf
-
[S20] Annual Report 2019: https://www1.hkexnews.hk/listedco/listconews/gem/2020/0327/2020032700775_c.pdf
-
[S21] Despatch of Circular (5 Apr 2024): https://www1.hkexnews.hk/listedco/listconews/gem/2024/0405/2024040501187.pdf
-
[S22] Notice of AGM (25 Mar 2022): https://www1.hkexnews.hk/listedco/listconews/gem/2022/0325/2022032501291.pdf
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Tenure / appointment | Prior and other roles | Education |
|---|---|---|---|---|
Mr. Wong Wai Chit (Vincent Wong) | Chairman, Executive Director; compliance officer | Founder of listed vehicle (5 Jul 2017); director of Fleming International Ltd (HK) since Jul 1993 per MarketScreener | Director of Fleming Group International Ltd, AVW International Ltd, Fleming International Vietnam Ltd, Success Glory Worldwide Ltd; formerly director of Natural Candle Holdings Ltd, Natural Light Malaysia Ltd, Purple Cloud Zi Yun Design Ltd, Silversmith Workshop Ltd | Not publicly disclosed (in sources reviewed) |
Mr. Wong Man Chit (Andrew Wong) | Chief Executive Officer, Executive Director | Founder of listed vehicle (5 Jul 2017); director of Fleming International Ltd (HK) since Jul 1993 per MarketScreener | Director of AVW International, Fleming Group International, Fleming International Vietnam, Success Glory Worldwide; formerly Natural Candle Holdings, Natural Light Malaysia | — |
Ms. Wong Wan Yan | Executive Director | — | — | — |
Mr. Chan Cheong Tat | Independent Non-Executive Director | On board since at least 2022 | — | — |
Mr. Ho Chi Wai | Independent Non-Executive Director | Re-elected at 2022 AGM | — | — |
Mr. Chu Kin Wang, Peleus | Independent Non-Executive Director | Re-elected at 2022 AGM | — | — |
“—” = not publicly disclosed.
Governance Overview
| Governance attribute | Status | Source |
|---|---|---|
Board size | 6 (3 executive, 3 INED) | [S1] |
Independence | 50% independent | computed from [S1] |
Chair/CEO separation | Separated in title (Chairman: Wong Wai Chit; CEO: Wong Man Chit), but the two are brothers and joint controlling shareholders acting in concert | [S1] |
Gender diversity | 1 of 6 directors female (16.7%) since Ms. Wong Wan Yan's appointment; board was all-male at Mar 2024 | [S2][S3] |
Audit committee | Exists; reviewed FY2025 accounts | [S1] |
CG Code compliance | Board states compliance with all applicable code provisions in FY2025 | [S1] |
Dealing code | GEM Rules 5.48–5.67 Required Standard of Dealings adopted; no non-compliance noted | [S1] |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Between Mar 2024 and Mar 2025 | Ms. Wong Wan Yan joins as executive director | Expands executive board from 2 to 3 |
10 Jun 2022 AGM | Re-election of Wong Wai Chit, Ho Chi Wai, Chu Kin Wang Peleus | Routine rotation |
Major Shareholders
| Shareholder | Shares | Stake (%) |
|---|---|---|
AVW International Limited (50% Wong Man Chit, 50% Wong Wai Chit) | 643,500,000 | 70.06 |
Public shareholders | 275,000,000 | 29.94 |
Total | 918,500,000 | 100.00 |
Competitive Landscape
Key Competitors
| Competitor | Type | Relevance to Hyfusin | Revenue (latest verified) | Source / status |
|---|---|---|---|---|
Kwung's Aroma Holdings (1925.HK, formerly Kwung's Holdings) | China-based ODM/OEM of candles, home fragrance and accessories; HK Main Board | Closest listed peer; export-focused candle maker | RMB882.1M FY2025 (−11.9%); RMB1,001.2M FY2024 | [S13] |
Qingdao Kingking Applied Chemistry (002094.SZ) | Chinese candle manufacturer/exporter (historically) | China-based candle exporter | — | — |
Bolsius | Dutch candle manufacturer (private) | European candle supply; UK exposure | — | — |
Empire Candle Co. | US candle manufacturer (private) | US private-label and licensed candles | — | — |
Yankee Candle (Newell Brands brand) | US brand owner with own manufacturing | Competes for shelf space; may also outsource | — | — |
Bath & Body Works (vendor base) | Specialty retailer with dedicated candle supply chain | Competes for US consumer spend; potential customer | — | — |
Other Chinese candle exporters | Contract manufacturers | Now facing EU anti-dumping duties on Chinese candles (since Aug 2025) per Kwung's | — | [S13] |
Vietnamese and other Southeast Asian contract manufacturers | Contract manufacturers | Compete on similar cost base and tariff position | — | — |
Indian candle exporters | Contract manufacturers | Alternative low-cost source | — | — |
Retailers' in-house / direct-sourcing programmes | Customers' alternatives | Bargaining power over price | — | Inferred |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Hyfusin FY2024 | Hyfusin FY2025 | Kwung's FY2024 | Kwung's FY2025 |
|---|---|---|---|---|
Revenue (local currency M) | 909.45 | 898.11 | 1,001.22 | 882.12 |
Revenue growth (%) | 5.0 | -1.2 | 24.1 | -11.9 |
Gross margin (%) | 38.7 | 31.6 | 22.4 | — |
Net profit (local currency M) | 171.43 | 101.47 | 118.66 | — |
Net margin (%) | 18.9 | 11.3 | 11.9 | — |
Recent Developments
All identified items are listed, followed by key earlier context.



